Hypertension and Vascular Research Division, Department of Internal Medicine, Henry Ford Hospital, Detroit, Michigan 48202, USA.
Am J Physiol Endocrinol Metab. 2012 Aug 15;303(4):E457-63. doi: 10.1152/ajpendo.00020.2012. Epub 2012 May 29.
Parathyroid hormone-related protein (PTHrP) increases renin release from isolated perfused kidneys and may act as an autacoid regulator of renin secretion, but its effects on renin in vivo are unknown. In vivo, PTHrP causes hypercalcemia and anorexia, which may affect renin. We hypothesized that chronically elevated PTHrP would increase plasma renin activity (PRA) indirectly via its anorexic effects, reducing sodium chloride (NaCl) intake and causing NaCl restriction. We infused male Sprague-Dawley rats with the vehicle (control) or 125 μg PTHrP/day (PTHrP) via subcutaneous osmotic minipumps for 5 days. To replenish NaCl consumption, a third group of PTHrP-infused rats received 0.3% NaCl (PTHrP + NaCl) in their drinking water. PTHrP increased PRA from a median control value of 3.68 to 18.4 ng Ang I·ml(-1)·h(-1) (P < 0.05), whereas the median PTHrP + NaCl PRA value was normal (7.82 ng Ang I·ml(-1)·h(-1), P < 0.05 vs. PTHrP). Plasma Ca(2+) (median control: 10.2 mg/dl; PTHrP: 13.7 mg/dl; PTHrP + NaCl: 14.1 mg/dl; P < 0.05) and PTHrP (median control: 0.03 ng/ml; PTHrP: 0.12 ng/ml; PTHrP + NaCl: 0.15 ng/ml; P < 0.05) were elevated in PTHrP- and PTHrP + NaCl-treated rats. Body weights and caloric consumption were lower in PTHrP- and PTHrP + NaCl-treated rats. NaCl consumption was lower in PTHrP-treated rats (mean Na(+): 28.5 ± 4.1 mg/day; mean Cl(-): 47.8 mg/day) compared with controls (Na(+): 67.3 ± 2.7 mg/day; Cl(-): 112.8 ± 4.6 mg/day; P < 0.05). NaCl consumption was comparable with control in the PTHrP + NaCl group; 0.3% NaCl in the drinking water had no effect on PRA in normal rats. Thus, our data support the hypothesis that PTHrP increases PRA via its anorexic effects, reducing NaCl intake and causing NaCl restriction.
甲状旁腺激素相关蛋白(PTHrP)可增加从分离的灌注肾脏中释放的肾素,并且可能作为肾素分泌的自体活性调节剂起作用,但其在体内对肾素的作用尚不清楚。在体内,PTHrP 引起高钙血症和厌食症,这可能影响肾素。我们假设慢性升高的 PTHrP 通过其厌食作用间接增加血浆肾素活性(PRA),减少氯化钠(NaCl)的摄入并导致 NaCl 限制。我们通过皮下渗透微型泵每天向雄性 Sprague-Dawley 大鼠输注载体(对照)或 125μg PTHrP/天(PTHrP)5 天。为了补充 NaCl 的消耗,第三组接受 PTHrP 输注的大鼠在饮用水中加入 0.3%NaCl(PTHrP+NaCl)。PTHrP 将 PRA 从 3.68 的中位数对照值增加到 18.4ng Ang I·ml(-1)·h(-1)(P<0.05),而 PTHrP+NaCl PRA 值正常(7.82ng Ang I·ml(-1)·h(-1),P<0.05 与 PTHrP)。血浆 Ca(2+)(中位数对照:10.2mg/dl;PTHrP:13.7mg/dl;PTHrP+NaCl:14.1mg/dl;P<0.05)和 PTHrP(中位数对照:0.03ng/ml;PTHrP:0.12ng/ml;PTHrP+NaCl:0.15ng/ml;P<0.05)在 PTHrP 和 PTHrP+NaCl 处理的大鼠中升高。PTHrP 和 PTHrP+NaCl 处理的大鼠体重和热量消耗较低。与对照组相比(Na(+):67.3±2.7mg/天;Cl(-):112.8±4.6mg/天;P<0.05),PTHrP 处理的大鼠的 NaCl 摄入量较低(平均值 Na(+):28.5±4.1mg/天;平均值 Cl(-):47.8mg/天)。在 PTHrP+NaCl 组中,NaCl 的摄入量与对照组相当;饮用水中的 0.3%NaCl 对正常大鼠的 PRA 没有影响。因此,我们的数据支持 PTHrP 通过其厌食作用增加 PRA 的假设,减少 NaCl 的摄入并导致 NaCl 限制。